536-33-4 Usage
Description
Ethionamide is an antimycobacterial compound that is active against M. tuberculosis (MICs = 0.3-1.25 μg/ml). It is activated via oxidation by flavin monooxygenase and inhibits the InhA enzyme involved in mycolic acid biosynthesis. Formulations containing ethionamide have been used in the second-line treatment of multi-drug resistant tuberculosis.
Chemical Properties
Yellow Solid
Originator
Trecator,Theraplix,France,1959
Uses
Different sources of media describe the Uses of 536-33-4 differently. You can refer to the following data:
1. Ethionamide is used in antimicrobials and in potency assay of test compounds on M. tuberculosis.
2. Antibacterial (tuberculostatic).
Indications
Ethionamide (Trecator) is a derivative of isonicotinic
acid and is chemically related to isoniazid. It is a secondary
agent used in combination when primary agents
are ineffective or contraindicated; it is a bacteriostatic
antituberculosis agent. Its exact mechanism of action
is unknown but is believed to involve inhibition of
oxygen-dependent mycolic acid synthesis. It is thought
that mutations in the region of the (inhA) gene that are
involved in mycolic acid synthesis can cause both isoniazid
and ethionamide resistance.
Definition
ChEBI: A thiocarboxamide that is pyridine-4-carbothioamide substituted by an ethyl group at position 2. A prodrug that undergoes metabolic activation by conversion to the corresponding S-oxide.
Manufacturing Process
Ethyl Propionyl-Pyruvate: 36 grams of methyl ethyl ketone and 73 grams of
ethyl oxalate are condensed in the presence of sodium ethylate, the reaction
mixture being refluxed in an alcoholic medium. 28 grams of the desired
product having a boiling point of 100° to 105°C/6 mm are obtained.3-Cyano-4-Carbethoxy-6-Ethyl-2-Pyridone: 205 cc of 60% alcohol, 22 grams
of the product just obtained, 11 grams of cyanacetamide and 4.5 cc of
piperidine are refluxed. 19 grams of product having a melting point of 211°C
are obtained.4-Carboxy-6-Ethyl-2-Pyridone: 30 grams of the cyanopyridone just obtained
are refluxed with concentrated hydrochloric acid. 13.5 grams of product
having a melting point of 308°C are obtained.2-Chloro-4-Carbethoxy-6-Ethyl-Pyridine: 26 grams of the product just
obtained are treated with 81 grams of phosphorus pentachloride in 45 cc of
phosphorus oxychloride. The phosphorus oxychloride is distilled off in a
vacuum and the residue is treated with absolute alcohol. After distillation
there are obtained 24 grams of product having a boiling point of 127° to
131°C/8 mm.Ethyl-2-Ethyl-Isonicotinate: 10 grams of the ester just obtained dissolved in
80 cc of absolute alcohol containing 5.5 grams of potassium acetate are
hydrogenated catalytically on 5% palladium black. 8 grams of product having
a boiling point of 120° to 124°C/14 mm are obtained.2-Ethyl-Isonicotinic-Amide: 20 grams of the ether just obtained are agitated,
with 25 cc of concentrated ammonia. 11 grams of product having a melting
point of 131°C are obtained.2-Ethyl-Isonicotinic Nitrile: The 11 grams of the amide just obtained are
treated with 15 grams of phosphorus anhydride at 160° to 180°C in a
vacuum. 6 grams of a liquid residue are obtained.Alpha-Ethyl-Isonicotinic Thioamide: The 6 grams of the liquid just obtained, in
solution in 15 cc of absolute alcohol containing 2 grams of triethanolamine,
are treated with hydrogen sulfide. 6.5 grams of the desired product having a
melting point of 166°C are obtained.
Brand name
Trecator (Wyeth.
Therapeutic Function
Antitubercular
General Description
Yellow crystals or canary yellow powder with a faint to moderate sulfide odor.
Air & Water Reactions
Insoluble in water.
Reactivity Profile
A thiocarbamate/amine. Thiocarbamates slowly decompose in aqueous solution to form carbon disulfide and methylamine or other amines. Such decompositions are accelerated by acids. Flammable gases are generated by the combination of thiocarbamates and dithiocarbamates with aldehydes, nitrides, and hydrides. Thiocarbamates and dithiocarbamates are incompatible with acids, peroxides, and acid halides.
Fire Hazard
Flash point data for Ethinamide are not available. Ethinamide is probably combustible.
Biochem/physiol Actions
Ethionamide is used as an anti-tuberculosis antibiotic and an inducer of hypothyroidism.
Mechanism of action
Evidence has been presented suggesting that the mechanism of action of ethionamide is similar to that of INH. Similar to INH, ethionamide is considered to be a pro-drug, which is converted via oxidation by catalase-peroxidase to an active acylating agent, ethionamide sulfoxide, which in turn inactivates the inhA enoyl reductase enzyme. In the case of ethionamide, it has been proposed that the ethionamide sulfoxide acylates Cys-243 in inhA protein.
Pharmacology
Ethionamide is well absorbed following oral administration.
It is rapidly and widely distributed to all body
tissues and fluids, including the cerebrospinal fluid.
Metabolism of ethionamide is extensive, and several dihydropyridine
metabolites are produced. Less than 1%
of the drug is eliminated in the urine unchanged.
GI disturbances, including nausea, vomiting, and intense
gastric irritation, are frequent. In addition, ethionamide
may cause a wide range of neurological side
effects, such as confusion, peripheral neuropathy, psychosis,
and seizures. Neurological effects can be minimized
by pyridoxine supplementation. Other rare side
effects include gynecomastia, impotence, postural hypotension,
and menorrhagia.
Clinical Use
2-Ethylthioisonicotinamide (Trecator SC) occurs as a yellowcrystalline material that is sparingly soluble in water. Thisnicotinamide has weak bacteriostatic activity in vitro but, becauseof its lipid solubility, is effective in vivo. In contrast tothe isoniazid series, 2-substitution enhances activity in thethioisonicotinamide series.Ethionamide is rapidly and completely absorbed followingoral administration. It is widely distributed throughoutthe body and extensively metabolized to predominantly inactiveforms that are excreted in the urine. Less than 1% ofthe parent drug appears in the urine.Ethionamide is considered a secondary drug for the treatmentof tuberculosis. It is used in the treatment of isoniazidresistanttuberculosis or when the patient is intolerant toisoniazid and other drugs. Because of its low potency, thehighest tolerated dose of ethionamide is usually recommended.Gastrointestinal intolerance is the most commonside effect associated with its use. Visual disturbances andhepatotoxicity have also been reported.
Synthesis
Ethionamide, 2-(ethyl)isonicotinthioamide (34.1.18), a derivative of isonicotinic acid, is synthesized by the following scheme. Diethyl oxalate is condensated with
methylethylketone in the presence of sodium ethoxide to form the ethyl ester of propionylpyruvic acid (34.1.12). Condensation of this with cyanoacetamide results in heterocyclization, to form 3-cyano-4-carboethoxy-6-ethyl-2-pyridone (34.1.13), which is
hydrolyzed with hydrochloric acid to give 4-carboxy-6-ethyl-2-pyridone (34.1.14).
Reacting this with a mixture of phosphorous oxychloride and pentachloride gives 6-ethyl-
2-chloroisonicotinic acid chloride, which is subsequently treated with ethyl alcohol to
obtain the ethyl ester of 6-ethyl-2-chloroisonicotinic acid (34.1.15). Reducing this with
hydrogen over a palladium catalyst removes the chlorine atom at position 2 of the pyridine
ring, giving the ethyl ester of 6-ethylisonicotinic acid (34.1.15). Interacting this with
ammonia, followed by dehydration of the resulting amide of 6-ethylisonicotinic acid using
phosphorous pentoxide gives the nitrile of 6-ethylisonicotinic acid (34.1.17). Finally,
reacting this with hydrogen sulfide gives ethionamide.
Metabolism
Ethionamide is orally active but is not well tolerated in a single large dose (>500 mg). The GI irritation can be reduced by administration with meals. Additional side effects may include central nervous system (CNS) effects, hepatitis, and hypersensitivities. Less than 1% of the drug is excreted in the free form, with the remainder of the drug appearing as one of six metabolites. Among the metabolites are ethionamide sulfoxide, 2-ethylisonicotinamide, and the N-methylated- 6-oxodihydropyridines.
Purification Methods
It crystallises from EtOH as lemon yellow needles. The hydrochloride crystallises from EtOH (+ few drops of HCl) as orange yellow needles with m 212-214o. [Kutscherowa et al. J Gen Chem USSR (English transl) 29 915 1959, Beilstein 22 III/IV 737.] It causes peripheral and occular neuropathy and is carcinogenic and teratogenic.
Check Digit Verification of cas no
The CAS Registry Mumber 536-33-4 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,3 and 6 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 536-33:
(5*5)+(4*3)+(3*6)+(2*3)+(1*3)=64
64 % 10 = 4
So 536-33-4 is a valid CAS Registry Number.
InChI:InChI=1/C8H10N2OS/c1-2-12-7-5-6(8(9)11)3-4-10-7/h3-5H,2H2,1H3,(H2,9,11)
536-33-4Relevant articles and documents
Efficient analoging around ethionamide to explore thioamides bioactivation pathways triggered by boosters in Mycobacterium tuberculosis
Prieri, Marion,Frita, Rosangela,Probst, Nicolas,Sournia-Saquet, Alix,Bourotte, Marilyne,Déprez, Benoit,Baulard, Alain R.,Willand, Nicolas
, p. 35 - 46 (2018/10/02)
Ethionamide is a key antibiotic prodrug of the second-line chemotherapy regimen to treat tuberculosis. It targets the biosynthesis of mycolic acids thanks to a mycobacterial bioactivation carried out by the Baeyer-Villiger monooxygenase EthA, under the control of a transcriptional repressor called EthR. Recently, the drug-like molecule SMARt-420, which triggers a new transcriptional regulator called EthR2, allowed the derepression a cryptic alternative bioactivation pathway of ethionamide. In order to study the bioactivation of a collection of thioisonicotinamides through the two bioactivation pathways, we developed a new two-step chemical pathway that led to the efficient synthesis of eighteen ethionamide analogues. Measurements of the antimycobacterial activity of these derivatives, used alone and in combination with boosters BDM41906 or SMARt-420, suggest that the two different bioactivation pathways proceed via the same mechanism, which implies the formation of similar metabolites. In addition, an electrochemical study of the aliphatic thioisonicotinamide analogues was undertaken to see whether their oxidation potential correlates with their antitubercular activity measured in the presence or in the absence of the two boosters.
A simple method for synthesis of thioamides and application in synthesis of 1,2,4-thiadiazoles
Cao, Xian Ting,Yang, Huiyong,Zheng, Hui,Zhang, Pengfei
, p. 509 - 517 (2018/03/27)
A novel, simple protocol is disclosed for the synthesis of 1,2,4-thiadiazoles starting from thioamides with Na2-eosin Y-sensitized titanium dioxide as catalyst through visible light irradiation (7 W blue LED light) and only 0.3 mol% catalysts were used. The raw material thioamides is prepared by aryl nitriles and sodium sulfide (Na2S9H2O) in DMF and in this reaction, readily available, inexpensive inorganic salt (Na2S9H2O) serves as the sulfur source and various functional groups of aryl nitriles were well and thioamides were synthesized successfully in gram-scale.
A THIONATION PROCESS AND A THIONATING AGENT
-
Page/Page column 13, (2012/08/27)
A process for transforming a group >C=O (I) in a compound into a group >C=S (II) or into a tautomeric form of group (II) in a reaction giving a thionated reaction product, by use of crystalline P2S5·2 C5H5N as a thionating agent. A thionating agent which is crystalline P2S5·2 C5H5N